Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
Citation data as of 2026-04-12 (OpenAlex).
Extracted findings
This paper hasn't been extracted into the knowledge graph yet. We're working through the corpus — 6379903 is in the queue.